Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.
Views | |
---|---|
CAPIVASERTIB RESTRICTS SARS-COV-2 CELLULAR ENTRY: A POTENTIAL CLINICAL APPLICATION FOR COVID-19 | 84 |
January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
---|---|---|---|---|---|---|---|
CAPIVASERTIB RESTRICTS SARS-COV-2 CELLULAR ENTRY: A POTENTIAL CLINICAL APPLICATION FOR COVID-19 | 3 | 3 | 5 | 8 | 0 | 3 | 3 |
Views | |
---|---|
Capivasertib restricts SARS-CoV-2.pdf | 23 |
Views | |
---|---|
United States | 50 |
Russia | 10 |
China | 7 |
Romania | 6 |
Argentina | 1 |
Australia | 1 |
Iran | 1 |
Sweden | 1 |
Turkey | 1 |
Views | |
---|---|
Oakland | 16 |
Louisville | 13 |
Moscow | 9 |
Brasov | 6 |
Shanghai | 6 |
Menlo Park | 3 |
Andover | 2 |
Ann Arbor | 2 |
Boardman | 2 |
Des Moines | 2 |